BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30122833)

  • 21. [Imaging diagnosis of dementia].
    Ishii K
    Nihon Rinsho; 2014 Apr; 72(4):681-6. PubMed ID: 24796097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol and the human brain: a systematic review of different neuroimaging methods.
    Bühler M; Mann K
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1771-93. PubMed ID: 21777260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Imaging Approaches in Dementia.
    Villemagne VL; Barkhof F; Garibotto V; Landau SM; Nordberg A; van Berckel BNM
    Radiology; 2021 Mar; 298(3):517-530. PubMed ID: 33464184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular neuroimaging in degenerative dementias.
    Jiménez Bonilla JF; Carril Carril JM
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):301-9. PubMed ID: 23933381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.
    Scheltens P; Korf ES
    Curr Opin Neurol; 2000 Aug; 13(4):391-6. PubMed ID: 10970055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging Methods Applicable in the Diagnostics of Alzheimer's Disease, Considering the Involvement of Insulin Resistance.
    Hnilicova P; Kantorova E; Sutovsky S; Grofik M; Zelenak K; Kurca E; Zilka N; Parvanovova P; Kolisek M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroimaging in Dementia.
    Risacher SL; Apostolova LG
    Continuum (Minneap Minn); 2023 Feb; 29(1):219-254. PubMed ID: 36795879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voxel-based correlation between coregistered single-photon emission computed tomography and dynamic susceptibility contrast magnetic resonance imaging in subjects with suspected Alzheimer disease.
    Cavallin L; Axelsson R; Wahlund LO; Oksengard AR; Svensson L; Juhlin P; Wiberg MK; Frank A
    Acta Radiol; 2008 Dec; 49(10):1154-61. PubMed ID: 18855165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in neuroimaging in frontotemporal dementia.
    Gordon E; Rohrer JD; Fox NC
    J Neurochem; 2016 Aug; 138 Suppl 1():193-210. PubMed ID: 27502125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression.
    Wei HC; Li B; Ng KP; Fu QX; Dong SJ; Ba MW; Kong M
    Chin Med J (Engl); 2021 Jul; 134(14):1709-1719. PubMed ID: 34397597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurostatistical imaging for diagnosing dementia: translational approach from laboratory neuroscience to clinical routine.
    Imabayashi E; Inoue T
    Neurosci Bull; 2014 Oct; 30(5):755-64. PubMed ID: 25193518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuroimaging of neurodegenerative and vascular disease in the secondary prevention of cognitive decline.
    Schaeffer MJ; Chan L; Barber PA
    Neural Regen Res; 2021 Aug; 16(8):1490-1499. PubMed ID: 33433462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.
    Peet BT; Spina S; Mundada N; La Joie R
    Neurotherapeutics; 2021 Apr; 18(2):728-752. PubMed ID: 34389969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroimaging in Dementia.
    Whitwell JL; Jack CR
    PET Clin; 2007 Jan; 2(1):15-24. PubMed ID: 27157703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of Biomarker Testing for Neuropathologically Defined Alzheimer Disease in Older Adults With Dementia.
    Fink HA; Linskens EJ; Silverman PC; McCarten JR; Hemmy LS; Ouellette JM; Greer NL; Wilt TJ; Butler M
    Ann Intern Med; 2020 May; 172(10):669-677. PubMed ID: 32340038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of positron emission tomography/computed tomography in dementia.
    Hinds SR; Stocker DJ; Bradley YC
    Radiol Clin North Am; 2013 Sep; 51(5):927-34. PubMed ID: 24010914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimaging techniques in epilepsy.
    Lai V; Mak HK; Yung AW; Ho WY; Hung KN
    Hong Kong Med J; 2010 Aug; 16(4):292-8. PubMed ID: 20683073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging in Dementias.
    Mahalingam S; Chen MK
    Semin Neurol; 2019 Apr; 39(2):188-199. PubMed ID: 30925612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.